选择最佳剂量在I/II阶段的剂量发现试验与情境强盗的最佳剂量选择:一个案例研究和实际建议
1GBDS, Bristol Myers Squibb, Boudry, Switzerland.
Journal of biopharmaceutical statistics
|February 28, 2025
概括
机器学习,特别是情境盗,为瘤学I/II期剂量检测试验提供了更有效的方法. 这项研究为使用这些先进方法来优化药物开发早期的剂量选择提供了实际建议.
科学领域:
- 临床试验 临床试验
- 机器学习在医学中的应用
- 制药指标 (Pharmacometrics) 是一个指标.
背景情况:
- 在早期药物开发中,经典的剂量检测试验往往是低效的.
- 响应适应性设计可以提高效率,但还不是最佳的.
- 机器学习 (ML) 方法,如上下文盗 (CB),显示出优化剂量选择的希望.
研究的目的:
- 关于使用ML用于瘤I/II期剂量检测试验设计的案例研究.
- 评估基于机器学习的设计的实际方面,包括中间分析和建模方法.
- 为在早期阶段的剂量选择中实施ML提供建议.
主要方法:
- 利用普森采样和贝叶斯启动程序用于上下文盗 (CB).
- 直接临床效用建模与联合疗效安全建模和模型独立方法 (多武装强盗) 的比较.
- 整合了缺乏信息的先前信息,并在各种剂量反应场景中进行了广泛的模拟.
主要成果:
- 模拟结果比较了设计设置和建模方法的不同组合.
- 在可行的剂量反应关系场景下评估了ML方法的性能.
- 在I/II期试验中确定了基于ML的剂量确定最佳策略.
结论:
- 拟议的ML方法,特别是上下文绑架,为I/II阶段的剂量检测提供了更有效和潜在的最佳方法.
- 为在临床试验设计中实施这些ML方法提供了实际建议.
- 该研究指导了选择适当的建模策略和设计参数以基于ML的剂量选择.
相关概念视频
01:03Dose-Response Relationship: Overview
2.9K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
2.9K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
111
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
111
01:11Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
01:22Dose-Response Relationship: Potency and Efficacy
4.1K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.1K
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
3.8K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
3.8K
01:12Analysis of Population Pharmacokinetic Data
214
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
214